Assunto: CARDIOPATIAS
ABNT
GUIDO, M. C et al. Losartan diminishes the expression of TGF-beta and improves cardiomyopathy in mice with Marfan syndrome. . Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2019APA
Guido, M. C., Debbas, V., Lopes, N. M., Ferreira Filho, J. C. A., Salemi, V. M. C., Pereira, L. V., et al. (2019). Losartan diminishes the expression of TGF-beta and improves cardiomyopathy in mice with Marfan syndrome. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Guido MC, Debbas V, Lopes NM, Ferreira Filho JCA, Salemi VMC, Pereira LV, Maranhão RC, Laurindo FRM. Losartan diminishes the expression of TGF-beta and improves cardiomyopathy in mice with Marfan syndrome. 2019 ;40 1538 res. P2577.[citado 2024 nov. 04 ]Vancouver
Guido MC, Debbas V, Lopes NM, Ferreira Filho JCA, Salemi VMC, Pereira LV, Maranhão RC, Laurindo FRM. Losartan diminishes the expression of TGF-beta and improves cardiomyopathy in mice with Marfan syndrome. 2019 ;40 1538 res. P2577.[citado 2024 nov. 04 ]